Table 3 Subgroup analysis according to serum ferritin level (n = 120).
From: Prognostic value of preoperative serum ferritin in cholangiocarcinoma patients
Variables | Values | Ferritin (ng/mL) | P-value | |
|---|---|---|---|---|
Low(n = 34) | High(n = 86) | |||
Age (years) | ≤ 60/>60 | 17/17 | 38/48 | 0.565 |
Gender | Female/Male | 16/18 | 37/49 | 0.688 |
CA19-9 (KU/L) | ≤ 35/>35 | 16/18 | 11/75 | 0.028 |
CA125 (KU/L) | ≤ 35/>35 | 31/3 | 67/19 | 0.090 |
CEA (ng/ml) | ≤ 5/>5 | 27/7 | 67/19 | 0.857 |
PA (mg/L) | ≤ 200/>200 | 13/21 | 41/44 | 0.501 |
ALB (g/L) | ≤ 35/>35 | 5/29 | 30/56 | 0.069 |
Tbil (µmol/L) | ≤ 26/>26 | 19/15 | 28/58 | 0.031 |
Ki-67 | ≤ 30/>30 | 21/13 | 43/43 | 0.244 |
CD34/31 | Yes/No | 17/17 | 24/62 | 0.021 |
NLR | ≤ 3.5/>3.5 | 24/10 | 48/38 | 0.137 |
LMR | ≤ 4.0/>4.0 | 21/13 | 65/21 | 0.130 |
PLR | ≤ 138.5/>138.5 | 24/10 | 60/26 | 0.930 |
Lymphatic metastasis | N0/N1-2/Nx | 19/5/8 | 38/28/20 | 0.171 |
Vascular invasion | No/Yes | 27/7 | 47/39 | 0.012 |
Differentiated degree | Low | 2 | 6 | 0.562 |
Low-medium | 14 | 48 | ||
Medium | 9 | 17 | ||
Medium-high | 5 | 12 | ||
High | 3 | 3 | ||
Postoperative adjuvant therapy | No/Yes | 11/23 | 51/35 | 0.008 |
